A panel talks about changes in how drugs are marketed, from direct-to-consumer ads to patient education and support groups funded by pharmaceutical companies.

Guests

  • Dr. Adrian Di Bisceglie Medical director of the American Liver Foundation and professor of internal medicine at St. Louis University
  • Mary Nell Lenhard Senior vice president for policy and representation at the Blue Cross Blue Shield Association
  • Dr. Michael Shaw Executive director of EthicAd, a nonprofit group formed to create standards for direct-to-consumer drug ads
  • Dr. Thomas Murray Fellow at the Hastings Center

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Tuskegee Study, 50 Years Later

Friday, Jul 29 2022Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.